In an elderly male with a reticulocyte count of 39.5%, estimated glomerular filtration rate of 59 mL/min/1.73 m², hemoglobin 12.2 g/dL, mean corpuscular volume 106 fL, and red cell distribution width 3.4 %, does this pattern indicate iron‑deficiency anemia?

No, this pattern is NOT consistent with iron deficiency anemia

The laboratory findings strongly argue against iron deficiency and instead suggest macrocytic anemia in the context of chronic kidney disease (CKD). The MCV of 106.1 fL indicates macrocytosis, which is fundamentally incompatible with iron deficiency anemia, where MCV is typically low (microcytic) or normal.

Key Laboratory Interpretation

Why This Is NOT Iron Deficiency:

• MCV 106.1 fL is elevated (macrocytic): Iron deficiency characteristically produces microcytic anemia (MCV <80 fL) or at most normocytic anemia. An MCV >100 fL points toward B12/folate deficiency, alcohol use, hypothyroidism, or medication effects 1.

• The reticulocyte count of 39.5% (assuming this is absolute count in K/µL, not percentage) is elevated, suggesting bone marrow response to anemia—this can occur in hemolysis or blood loss, but the macrocytosis rules out simple iron deficiency.

• GFR 59 mL/min/1.73m² indicates CKD Stage 3a: While CKD commonly causes anemia and iron deficiency is frequent in CKD, the macrocytic picture here suggests alternative or additional etiologies 1.

What the Evidence Shows About Iron Deficiency Diagnosis:

In CKD patients specifically, iron deficiency assessment requires ferritin and transferrin saturation, not MCV 1. Recent research confirms that MCV is not a reliable predictor of iron deficiency in CKD patients 2. The 2021 British Society of Gastroenterology guidelines emphasize that absolute iron deficiency in predialysis CKD is defined as:

• Transferrin saturation ≤20% AND
• Serum ferritin ≤100 μg/L 1

Modern Reticulocyte Parameters:

Recent studies demonstrate that reticulocyte hemoglobin content (RHe/CHr) and mean reticulocyte volume (MRV) are superior to traditional markers for detecting iron-restricted erythropoiesis in elderly patients 3. In elderly anemic patients:

• MRV <97.4 fL identifies iron-restricted erythropoiesis with 88.2% sensitivity and 82.7% specificity 3
• RHe <30.4 pg has 82.4% sensitivity and 79.8% specificity 3

However, your patient's macrocytic MCV makes iron deficiency highly unlikely regardless of reticulocyte parameters.

Clinical Approach for This Patient:

1. Check B12 and folate levels immediately - macrocytosis in elderly with CKD most commonly reflects nutritional deficiency

2. Obtain ferritin and transferrin saturation - to definitively exclude iron deficiency using CKD-specific thresholds (ferritin ≤100 μg/L, TSAT ≤20%) 1

3. Review medications - methotrexate, trimethoprim, anticonvulsants, and other drugs can cause macrocytosis

4. Assess for hemolysis - the elevated reticulocyte count warrants checking LDH, haptoglobin, and indirect bilirubin

5. Consider thyroid function - hypothyroidism causes macrocytic anemia

Critical Pitfall to Avoid:

Do not assume anemia in CKD equals iron deficiency. While iron deficiency is common in CKD (and may coexist), the macrocytic picture demands investigation for B12/folate deficiency first 1. The elderly are particularly prone to multiple contributing causes of anemia 1.

If Iron Studies Confirm Deficiency Despite Macrocytosis:

This would indicate combined deficiency (both iron AND B12/folate), requiring treatment of both. In CKD patients with confirmed iron deficiency, oral iron can be tried in predialysis patients, but intravenous iron is often needed if oral therapy fails or dialysis begins 1. Management should involve nephrology consultation given the GFR of 59 1.